Mettrum Health Corp - Einer der wenigen lizensierten Cannabis Anbauer aus Kanada - 500 Beiträge pro Seite

[Findik2]

Mettrum Health Corp
ISIN: CA5926891030
WKN: A12DRS

Der erste Hype ist rum und nahezu alle Werte sind verbrannt. Nun ja da wollte Ich mal schauen wo es sich wirklich mal wieder lohnen könnte zu investieren. Habe hier Mettrum Health gefunden. Sind eine der wenigen in Kanada zugelassen Cannabisvertreiber.

Der Cannabisproduzent ist ansässig in Kanada. Wurde vor nicht allzu langer Zeit gegründet und generiert schon recht ordentlichen Umsatz.

Figures in CDN $

Dec 31, 2014
Sept 30, 2014
June 30, 2014
Mar 31, 2014
Dec 31, 2013
Sept 30, 2013
June 30, 2013
Mar 31, 2013

Revenue
689,478
806,412
715,131
170,349
-
-
-
-

Net loss
(1,400,702)
(2,786,530)
(1,220,425)
(560,732)
(205,219)
(52,815)
(11,548)
($,919)

Net loss per share – basic and fully diluted
(0.04)
(0.14)
(0.07)
(0.04)
(0.02)
(0.00)
(0.00)
(0.00)

Das sind die momentan lizensierten Cannabis Hersteller, davon sind Aphiry, Bedrocan Mettrum, OrganiGram und Tweed AGs:

Fully Authorised Licensed Producers
Name of licensed producer Phone number
Aphria 1-844-427-4742
Bedrocan Canada Inc. 1-855-420-7887
Broken Coast Cannabis Ltd. 1-888-486-7579
Canna Farms Ltd. 1-855-882-0988
CanniMed Ltd. 1-855-787-1577
CannTrust Inc. 1-855-794-2266
Delta 9 Bio-Tech Inc. 1-855-245-1259
In The Zone Produce Ltd. 1-800-420-1707
MariCann Inc. 1-844-627-4226 (MARICANN)
MedReleaf Corp. 1-855-4-Releaf (73-5323)
Mettrum Ltd. 1-844-638-8786 (METTRUM)
OrganiGram Inc. 1-855-961-9420
The Peace Naturals Project Inc 1-888-64-PEACE (73223)
RedeCan Pharm 1-905-892-6788
Thunderbird Biomedical Inc. 1-800-757-3536
Tilray 1-844-TILRAY1 (845-7291)
Tweed Inc. 1-855-55-TWEED (89333)
Whistler Medical Marijuana Corp. 1-604-962-3440

Mettrum wurde von Health Canada / Regierung eingehendts strengstens durchleuchtet. Lt. Quelle von November 14 haben lediglich 22 Antragssteller von 1100 Antragsstellern eine Lizenz erhalten. 291 seien in Bearbeitung.

http://www.cbc.ca/news/politics/medical-marijuana-applicant-…

Soweit so gut...

Hier noch ein Auszug aus dem Geschäftsbericht:
Management Discussion and Analysis For the three and nine months ended December 31, 2014 Report Seite 8
Outlook
Mettrum started producing medical cannabis after it received its MMPR License and began selling in January 2014. Mettrum has been focusing on maximizing production yield and refining its production techniques, as well as building out its production capacity. As of February 10, 2015, the Company has over 2,200 registered clients. After temporarily suspending registration in July of 2014, the Company started accepting new clients after it received an MMPR license for its Agripharm facility. The Company’s Agripharm facility received its license to produce and sell 9,000 cannabis plants on December 11, 2014.
In addition, subsequent to the end of the quarter, Mettrum entered into an agreement to acquire up 150 kg of dried cannabis from a third party supplier. This cannabis is required to meet Mettrum’s rigorous quality standards. This additional supply of product will ensure adequate product is available to service existing clients and the increased additional clients. Mettrum amended its license at its Bowmanville north facility to increase ability to sell up 1,200 kg per year in order to accommodate the additional production from Agripharm and the third party purchase.
Mettrum purchased additional land and buildings in Bowmanville, Ontario and completed the first phase of the build out. Mettrum has filed an application to have the new facility licensed under the MMPR and has prepared the facility for a Health Canada inspection which is required prior to receiving this license. This facility when fully built out has the potential to produce up to 8,000 kg of medical cannabis.
Mettrum must comply with all Health Canada regulations as established under the MMPR. To date, Mettrum has undergone numerous Health Canada inspections including an annual review and, with respect to all observations, Health Canada has acknowledged Mettrum’s corrective and/or preventative action plans as satisfactory.

Kurz Zusammengefasst
Kunden: 2200
Genehmigte Pflanzenanzahl: 9000 Stück
Anbaumenge Jährlich: 1200 Kg das sind 1.200.000 g
Zukauf Jährlich: 150 Kg das sind 150.000 g

Lt. Webseite verkaufen Sie das Gramm für ca. 7,50


Momentanes Problem ist die Deckelung der Regierung. Das heißt ein Wachstum des Unternehmens ist momentan schwierig. Metrum hat einen Mitbewerber (?) aufgekauft und kann daher nochmal mehr anbauen. (?)

Die LP`s dürfen nach dem neuen MMPR (siehe http://www.marihuana-aktien.de/news/canada/ ) maximal so viel produzieren, wie sie von Health Canada genehmigt bekommen, zumindest so wie ich das verstehe.
Für jede Produktionsausweitung muss erneut eine neue MMPR-Lizenz beantragt werden, die erneut die 7 verschiedenen Kontrollen von Health Canada durchlaufen muss:

Process Steps for Becoming a Licensed Producer:

Step 1: Preliminary Screening
When an application is received, it undergoes a preliminary screening for completeness. If an application is not complete, it will be returned. If an application is complete, it will be assigned an application number. The application number means that the application has completed the preliminary screening.

Step 2: Enhanced Screening
Once an application has been assigned an application number, it will be reviewed to ensure: that the location of the proposed site does not pose a risk to public health, safety and security; that the proposed security measures outlined in the application meet the requirements of the MMPR; and the proposed quality assurance person has the appropriate credentials to meet the good production requirements outlined in Division 4 of the MMPR. As a reminder, it is the responsibility of the applicant to ensure that they are in compliance with all applicable provincial, territorial, and municipal legislation, regulations and bylaws, including zoning restrictions.

Step 3: Security Clearance
Once the screening of an application is complete, the security clearance forms for key personnel will be sent for processing. The time required to conduct mandatory security checks varies with each application. Applicants should expect that security clearances will take several months at a minimum. Health Canada and the RCMP are not able to provide updates on the status of security checks. Applications will only advance to the review stage once the security clearances for the key personnel are completed. Please note that until such a time as Health Canada receives the results of the security checks, there will be no further communication from Health Canada.

Step 4: Review
Once all security clearances are obtained, an application will be thoroughly reviewed to validate the information provided. Given the extensive review process, applicants should anticipate communicating with the Office of Controlled Substances multiple times to provide clarifications on the application. Physical security plans will be reviewed and assessed in detail at this stage. Please note that applicants must meet a minimum of a level 7 to be considered for a licence. Information on the physical security directive can be found on the Health Canada website.

Step 5: Ready to build letter (if required by applicant)
Once the review of the application has been completed and it is confirmed that all requirements in the MMPR are met, applicants may request that Health Canada issue a "ready to build letter".
The "ready to build letter" is a notice informing the applicant that, if the licensed producer's site is built to the specifications outlined in the application that the physical security measures would meet the requirements of the MMPR. The "ready to build letter" is not a guarantee that a licence will be issued. The issuance of a licence under the MMPR is dependent upon the completion of a satisfactory inspection and is contingent on all key personnel identified in your application receiving the security clearance required under the MMPR.

Step 6: Pre­licence inspection
Upon confirmation from the applicant that the site has been fully built and security measures are in place, a pre­licence inspection will be scheduled. If any deficiencies are identified, they will be communicated to the applicant and must be addressed prior to a licence being issued.

Step 7: Licensing
Once it has been confirmed through the pre­licence inspection that the applicant meets all the requirements of the MMPR, a licence will be issued. Health Canada has introduced a staged process for the issuance of licences. Applicants will first be issued a licence to produce only. This will enable Health Canada inspectors to confirm that the first batch of dried marijuana produced meets the good production practices and record keeping requirements outlined in the MMPR. It also allows Health Canada to verify the test results of the dried marijuana (e.g. for microbial and chemical contaminants) to ensure that the dried marijuana meets all quality control requirements before it is made available for sale.

Quelle: http://www.hc-sc.gc.ca/dhp-mps/marihuana/info/application_st…

Momentan herscht in Kanada ene gewisse unsichere Rechtslage. Wenn die Gesetze kippen sollten sieht es natürlich für die Branche wieder schlechter aus. Aber das wollen wir ja nicht hoffen.

Aktie wurde meines Wissens auch nicht in irgendwelchen dubiosen Seiten gepusht. Macht auch einen seriösen Anschein m.M. Allgemein gibt es wenige Infos zu dem Unternehmen.

Hier noch ein Link zu einer deutschen Info Seite über Cannabis Stocks. Habe mich auch schon mit dem Betreiber dieser Webseite unterhalten, er sieht auch momentan das Problem das der Umsatz von der Regierung noch gedeckelt wird.
http://www.marihuana-aktien.de/unternehmensadresen-m/mettrum…

So hier noch ein schöner Seekingalpha Artikel u.a. auch mit METTRUM:
http://seekingalpha.com/article/2790265-canadas-marijuana-ma…

Wer hat mehr Infos bzw. kennt sich mit dem Thema aus. Einfach posten.

Wie immer: Keine Kauf / Verkauf / Handelsempfehlung. Dient lediglich zum Diskussionsaustausch über das Unternehmen.

[Findik2]

https://www.mettrum.com/investors/news-releases/mettrum-anno…

Mettrum Announces Fourth Quarter and Full Fiscal Year 2015 Financial Results
Current registered client count increased to 3,000


Fiscal 2015 Financial Highlights:

Revenues for the first full year of operations totaled $3,058,711
Grams sold for the first full year of operations totaled 418,372 grams
Gross Margin at 42.4 percent
Q4 2015 versus Q3 2015 Financial Highlights:

Revenues increase approximately 23 percent to $847,690
Grams sold increase by 22 percent to 115,065 grams
Gross Margin at 60.5 percent


Toronto, Ontario, June 25, 2015 – Mettrum Health Corp. (“Mettrum” or the “Company”) (TSXV:MT) (TSXV:MT.WT), a vertically integrated agri-pharmaceutical company focused on research, development, production and distribution of Health Canada licensed cannabis products, announced today its fourth quarter and full year financial results for the period ended March 31, 2015.

For the year ended March 31, 2015, Mettrum revenues increased to $3,058,711 on 418,372 grams of medical cannabis sold. Average selling price per gram increased to $7.32 from $7.02 in the prior year. For the full year, gross profit also significantly increased to $1,297,567 or 42.4 percent of revenues. Loss from operations, net loss and loss per share amounted to $6,211,247, $7,035,936 and $0.27 per share, respectively, which are attributed to the continued growth of the business. These amounts include the related costs for completing a reverse merger with a capital pool corporation to become a public company.

For the three-month period ended March 31, 2015, Mettrum’s revenues increased by 22% percent to $847,690 on 115,065 grams of medical cannabis sold over the quarter ended December 31, 2014. Average price per gram for the quarter increased to $7.53, versus $7.25 during quarter ended December 31, 2014. During the fourth quarter, gross profit more than doubled to $513,352 or 60.5 percent of revenues as the Company continued its efforts towards further operational efficiencies.

For the three-month period ended March 31, 2015, loss from operations, net loss and loss per share amounted to $1,850,059, $1,795,416 and $0.05 per share, respectively, which are attributed to the continued growth of the business.



Figures in CDN $ For the three months ended Mar 31, 2015 For the three months ended Dec 31, 2014 For the year ended Mar 31, 2015 For the year ended Mar 31, 2014
Grams sold 115,065 94,695 418,372 23,873
Revenue 847,690 689,478 3,058,711 170,349
Gross margin 513,352 237,588 1,297,567 252,946
Operating expenses 2,363,411 1,613,427 7,508,814 1,000,231
EBITDA (1,521,814) (1,168,349) (5,471,788) (683,174)
Loss from operations (1,850,059) (1,375,839) (6,211,247) (747,285)
Net loss (1,795,416) (1,233,565) (7,035,936) (830,314)
Net loss per share basic
and diluted (0.05) (0.04) (0.27) (0.07)

As at June 23, 2015, the Company has increased registered clients to 3,000 and management maintains its ongoing commitment to further growth in clients through maintaining product quality, customer service, support and tools to assist both clients and physicians when considering Mettrum as a leading producer and distributor of medical cannabis.

As at March 31, 2015, the Company maintained a solid balance sheet with a net cash position of approximately $21 million.

“I am very pleased with our progress and financial performance during the fourth quarter, and particularly excited with Mettrum Creemore being awarded its Health Canada license. Our sales and marketing team’s ability to quickly respond and focus their efforts on growing the Company’s client base is evidenced by our current registrations of 3,000 clients,” commented Michael Haines, CEO of the Company. “Our objective from the early days was to be the industry leader. With our operational and financial performance to date, coupled with our level of confidence in the near, mid and long term, I am optimistic with our prospects as we report our progress during the course of what is shaping to be a great start to our new fiscal year.”

Mettrum is pleased that the license at its Mettrum Creemore facility has been renewed effective June 11, 2015. In addition, Mettrum Creemore is scheduled to have Health Canada return later this month to inspect the rest of the facility including 33 more grow rooms. Mettrum Creemore currently has 13 grow rooms licensed to grow medical cannabis.

Mettrum completed its acquisition of Oilseed Works Inc. (“OWI”) currently operating as Hempola on April 30, 2015. The acquisition, and the 20 years of experience OWI brings to the organization, provides Mettrum with immediate access to the industrial cannabis and functional foods market. It solidifies Mettrum as the leading multi-faceted provider of Health Canada licensed cannabis products.

About Mettrum Health Corp.

Mettrum Health Corp. is Tier 1 Industry Issuer listed on TSX Venture Exchange. Mettrum Ltd., a wholly owned subsidiary of the Company, is a Toronto-based company and a licensed producer of medical cannabis under the Marihuana for Medical Purposes Regulations (Canada) issued pursuant to the Controlled Drugs and Substances Act (Canada) (the “MMPR”), which came into effect on October 1, 2013. Mettrum received its first license from Health Canada under the MMPR on November 1, 2013 and began production of medical cannabis at its first production facility in Bowmanville, Ontario. Mettrum received its second license from Health Canada under the MMPR on December 11, 2014 for its other wholly-owned subsidiary, Agripharm Corp., at Mettrum Creemore facility in Clearview, Ontario. With the Company’s two licenses, Mettrum is a leading producer and vendor of medical cannabis under the MMPR system.

For more information, please contact:

Mettrum Health Corp.

Ali Mahdavi
Director, Investor Relations
Phone: [phone]
E-mail: [e-mail]

Keelan Green
Media Relations
Phone: [phone]
E-mail: [e-mail]

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION: This news release includes
certain “forward-looking statements” under applicable Canadian securities legislation. Forward-looking
statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable,
are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and
future events to differ materially from those expressed or implied by such forward-looking statements. Such factors
include, but are not limited to: general business, economic, competitive, political and social uncertainties; delay or
failure to receive board, shareholder or regulatory approvals; and the results of operations. There can be no
assurance that such statements will prove to be accurate, as actual results and future events could differ materially
from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking
statements. The Company and Mettrum disclaim any intention or obligation to update or revise any forward-looking
statements, whether as a result of new information, future events or otherwise, except as required by law.

Neither the Exchange nor its Regulation Services Provider (as that term is defined in the policies of the
Exchange) accepts responsibility for the adequacy or accuracy of this Press release.

[Findik2]

Vorerst wieder rausgegangen. Charttechnisch geht es momentan runter. Bleibt aber weiter auf der Watchlist.